Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Return on Assets (2020 - 2024)

RAPT Therapeutics' Return on Assets history spans 5 years, with the latest figure at 0.97% for Q3 2024.

  • For Q3 2024, Return on Assets fell 41.0% year-over-year to 0.97%; the TTM value through Sep 2024 reached 0.97%, down 41.0%, while the annual FY2023 figure was 0.58%, 21.0% down from the prior year.
  • Return on Assets for Q3 2024 was 0.97% at RAPT Therapeutics, down from 0.91% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.28% in Q3 2021 and bottomed at 0.97% in Q3 2024.
  • The 5-year median for Return on Assets is 0.39% (2023), against an average of 0.5%.
  • The largest annual shift saw Return on Assets increased 12bps in 2022 before it crashed -46bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.41% in 2020, then increased by 22bps to 0.32% in 2021, then dropped by -13bps to 0.36% in 2022, then crashed by -89bps to 0.68% in 2023, then plummeted by -43bps to 0.97% in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Return on Assets are 0.97% (Q3 2024), 0.91% (Q2 2024), and 0.78% (Q1 2024).